Global Hematology Analyzer and Reagent Market Research Report 2022
Hematology analyzers, coagulation analyzers, flow cytometers, and slide strainers are some of the hematologic instruments used to analyze blood and blood-related disorders. Hematology analyzers are highly specialized instruments used to count the number of white blood cells, red blood cells, and platelets. Hematology analyzers are made up of multiple analytical modules with unique sample preparation processes. They assist in the diagnosis of various diseases, such as infections, anemia, viruses, diabetes, genetic problems, and cancer. It also regulates plasma drug level for both therapeutic and illicit drugs.
Due to the COVID-19 pandemic, the global Hematology Analyzer and Reagent market size is estimated to be worth US$ 8176.7 million in 2021 and is forecast to a readjusted size of US$ 12420 million by 2028 with a CAGR of 6.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hematology Analyzer and Reagent market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hematology Analyzer and Reagent landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Analyzer accounting for % of the Hematology Analyzer and Reagent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Hematology Analyzer and Reagent include Bio-Rad Laboratories, Immucor, Ortho Clinical Diagnostics, Grifols, Haemotec, Hemo bioscience, Institut de Biotechnologies Jacques Boy, Sysmex Corporation and Beckman Coulter, Inc., etc. In terms of revenue, the global 3 largest players have a % market share of Hematology Analyzer and Reagent in 2021.
This report focuses on Hematology Analyzer and Reagent volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hematology Analyzer and Reagent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Hematology Analyzer and Reagent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Analyzer
Reagent
Segment by Application
Hospital
Blood Bank
Research Institutions
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bio-Rad Laboratories
Immucor
Ortho Clinical Diagnostics
Grifols
Haemotec
Hemo bioscience
Institut de Biotechnologies Jacques Boy
Sysmex Corporation
Beckman Coulter, Inc.
Abbott Laboratories
Siemens Healthcare
Bayer
HORIBA ABX SAS
A.S.L
Boule Diagnostics AB
Research and Production Complex “Biopromin” Ltd
Mindray
Sinnowa
Hui Zhikang
Jinan Hanfang
Gelite
Sinothinker
Bio-Rad Laboratories
Nihon Kohden
Abaxis
Due to the COVID-19 pandemic, the global Hematology Analyzer and Reagent market size is estimated to be worth US$ 8176.7 million in 2021 and is forecast to a readjusted size of US$ 12420 million by 2028 with a CAGR of 6.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hematology Analyzer and Reagent market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hematology Analyzer and Reagent landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Analyzer accounting for % of the Hematology Analyzer and Reagent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Hematology Analyzer and Reagent include Bio-Rad Laboratories, Immucor, Ortho Clinical Diagnostics, Grifols, Haemotec, Hemo bioscience, Institut de Biotechnologies Jacques Boy, Sysmex Corporation and Beckman Coulter, Inc., etc. In terms of revenue, the global 3 largest players have a % market share of Hematology Analyzer and Reagent in 2021.
This report focuses on Hematology Analyzer and Reagent volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hematology Analyzer and Reagent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Hematology Analyzer and Reagent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Analyzer
Reagent
Segment by Application
Hospital
Blood Bank
Research Institutions
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bio-Rad Laboratories
Immucor
Ortho Clinical Diagnostics
Grifols
Haemotec
Hemo bioscience
Institut de Biotechnologies Jacques Boy
Sysmex Corporation
Beckman Coulter, Inc.
Abbott Laboratories
Siemens Healthcare
Bayer
HORIBA ABX SAS
A.S.L
Boule Diagnostics AB
Research and Production Complex “Biopromin” Ltd
Mindray
Sinnowa
Hui Zhikang
Jinan Hanfang
Gelite
Sinothinker
Bio-Rad Laboratories
Nihon Kohden
Abaxis
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
